E-cadherin expression in invasive breast cancer

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 4, 2008, Pages 517-523

  Suciu, C ^a   Cîmpean, Anca Maria ^a   Mureşan, Anca Maria ^a   Izvernariu, D ^a   Raica, M ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Breast cancer; E cadherin; Immunohistochemistry; Invasive; Prognosis

Indexed keywords

CADHERIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 70449931494     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. QURESHI H. S., LINDEN M. D., DIVINE G., RAJU U. B., E-cadherin status in breast cancer correlates with histologictype but does not correlate with established prognostic parameters, Am J Clin Pathol, 2006, 125(3):377-385.
2. HIROHASHI S., Inactivation of the E-cadherin-mediated cell adhesion system in human cancers, Am J Pathol, 1998, 153(2):333-339.
3. JIANG W. G., MANSEL R. E., E-cadherin complex and its abnormalities in human breast cancer, Surg Oncol, 2000, 9(4):151-171.
4. NOLLET F., KOOLS P., van Roy F., Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members, J Mol Biol, 2000, 299(3):551-572.
5. TAKEICHI M., Cadherins in cancer: implications for invasion and metastasis, Curr Opin Cell Biol, 1993, 5(5):806-811.
6. KOWALSKI P. J., RUBIN M. A., KLEER C. G., E-cadherin expression in primary carcinomas of the breast and its distant metastases, Breast Cancer Res, 2003, 5(6):R217-R222.
7. HOWARD M. E., LAU K. S., LYLES H. R., BIRDSONG G. G., UMBREIT J. N., KOCHHAR R., Expression of e-cadherin in high-risk breast cancer, J Cancer Res Clin Oncol, 2005, 131(1):14-18.
8. OKA H., SHIOZAKI H., KOBAYASHI K., INOUE M., TAHARA H., KOBAYASHI T., TAKATSUKA Y., MATSUYOSHI N., HIRANO S., TAKEICHI M., MORI T., Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis, Cancer Res, 1993, 53(7):1696-1701.
9. HUNT N. C., Douglas-Jones A. G., JASANI B., MORGAN J. M., PIGNATELLI M., Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas, Virchows Arch, 1997, 430(4):285-289.
10. SIITONEN S. M., KONONEN J. T., HELIN H. J., RANTALA I. S., HOLLI K. A., ISOLA J. J., Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer, Am J Clin Pathol, 1996, 105(4):394-402.
11. GURIEC N., MARCELLIN L., GAIRARD B., CALDÉROLI H., WILK A., RENAUD R., BERGERAT J. P., OBERLING F., E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival, Invasion Metastasis, 1996, 16(1):19-26.
12. CHARPIN C., GARCIA S., BONNIER P., MARTINI F., ANDRAC L., CHOUX R., LAVAUT M. N., ALLASIA C., Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival, Am J Clin Pathol, 1998, 109(4):431-438.
13. LIPPONEN P., SAARELAINEN E., JI H., AALTOMAA S., SYRJÄNEN K., Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer, J Pathol, 1994, 174(2):101-109.
14. COLPAERT C. G., VERMEULEN P. B., BENOY I., SOUBRY A., van Roy F., van Beest P., GOOVAERTS G., DIRIX L. Y., van DamP., FOX S. B., HARRIS A. L., van Maarck E. A., Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression, Br J Cancer, 2003, 88(5):718-725.
15. KLEER C. G., van Golen K. L., BRAUN T., MERAJVER S. D., Persistent E-cadherin expression in inflammatory breast cancer, Mod Pathol, 2001, 14(5):458-463.
16. ZSCHIESCHE W., SCHÖNBORN I., BEHRENS J., HERRENKNECHT K., HARTVEIT F., LILLENG P., BIRCHMEIER W., Expression of E-cadherin and catenins in invasive mammary carcinomas, Anticancer Res, 1997, 17(1B):561-567.
17. HEIMANN R., LAN F., MCBRIDE R., HELLMAN S., Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin, Cancer Res, 2000, 60(2):298-304.
18. PARKER C., RAMPAUL R. S., PINDER S. E., BELL J. A., WENCYK P. M., BLAMEY R. W., NICHOLSON R. I., ROBERTSON J. F., E-cadherin as a prognostic indicator in primary breast cancer, Br J Cancer, 2001, 85(12):1958-1963.
19. CHARPIN C., GARCIA S., BOUVIER C., DEVICTOR B., ANDRAC L., CHOUX R., LAVAUT M., E-cadherin quantitative immunocytochemical assays in breast carcinomas, J Pathol, 1997, 181(3):294-300.
20. ELSTON C. W., ELLIS I. O., Pathologic prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 1991, 19(5):403-410.
21. GREENLEE R. T., Hill-Harmon M. B., MURRAY T., THUN M., Cancer statistics, 2001, CA Cancer J Clin, 2001, 51(1):15-36.